The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
K Cells-Global Market Insights and Sales Trends 2025
Synopsis
The global K Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of K Cells in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling K Cells market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for K Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the K Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for K Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global K Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global K Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, K Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of K Cells covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global K Cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Global K Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global K Cells market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global K Cells market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of K Cells manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of K Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global K Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of K Cells in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling K Cells market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for K Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the K Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for K Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global K Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global K Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, K Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of K Cells covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global K Cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Global K Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global K Cells market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global K Cells market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of K Cells manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of K Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 K Cells Market Overview
1.1 K Cells Product Overview
1.2 K Cells Market Segment by Type
1.2.1 Mogamulizumab
1.2.2 Lorvotuzumab Mertansine
1.2.3 Others
1.3 Global K Cells Market Size by Type
1.3.1 Global K Cells Market Size Overview by Type (2018-2029)
1.3.2 Global K Cells Historic Market Size Review by Type (2018-2023)
1.3.3 Global K Cells Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America K Cells Sales Breakdown by Type (2018-2023)
1.4.2 Europe K Cells Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific K Cells Sales Breakdown by Type (2018-2023)
1.4.4 Latin America K Cells Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa K Cells Sales Breakdown by Type (2018-2023)
2 Global K Cells Market Competition by Company
2.1 Global Top Players by K Cells Sales (2018-2023)
2.2 Global Top Players by K Cells Revenue (2018-2023)
2.3 Global Top Players by K Cells Price (2018-2023)
2.4 Global Top Manufacturers K Cells Manufacturing Base Distribution, Sales Area, Product Type
2.5 K Cells Market Competitive Situation and Trends
2.5.1 K Cells Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by K Cells Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in K Cells as of 2022)
2.7 Date of Key Manufacturers Enter into K Cells Market
2.8 Key Manufacturers K Cells Product Offered
2.9 Mergers & Acquisitions, Expansion
3 K Cells Status and Outlook by Region
3.1 Global K Cells Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global K Cells Historic Market Size by Region
3.2.1 Global K Cells Sales in Volume by Region (2018-2023)
3.2.2 Global K Cells Sales in Value by Region (2018-2023)
3.2.3 Global K Cells Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global K Cells Forecasted Market Size by Region
3.3.1 Global K Cells Sales in Volume by Region (2024-2029)
3.3.2 Global K Cells Sales in Value by Region (2024-2029)
3.3.3 Global K Cells Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global K Cells by Application
4.1 K Cells Market Segment by Application
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Others
4.2 Global K Cells Market Size by Application
4.2.1 Global K Cells Market Size Overview by Application (2018-2029)
4.2.2 Global K Cells Historic Market Size Review by Application (2018-2023)
4.2.3 Global K Cells Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America K Cells Sales Breakdown by Application (2018-2023)
4.3.2 Europe K Cells Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific K Cells Sales Breakdown by Application (2018-2023)
4.3.4 Latin America K Cells Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa K Cells Sales Breakdown by Application (2018-2023)
5 North America K Cells by Country
5.1 North America K Cells Historic Market Size by Country
5.1.1 North America K Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America K Cells Sales in Volume by Country (2018-2023)
5.1.3 North America K Cells Sales in Value by Country (2018-2023)
5.2 North America K Cells Forecasted Market Size by Country
5.2.1 North America K Cells Sales in Volume by Country (2024-2029)
5.2.2 North America K Cells Sales in Value by Country (2024-2029)
6 Europe K Cells by Country
6.1 Europe K Cells Historic Market Size by Country
6.1.1 Europe K Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe K Cells Sales in Volume by Country (2018-2023)
6.1.3 Europe K Cells Sales in Value by Country (2018-2023)
6.2 Europe K Cells Forecasted Market Size by Country
6.2.1 Europe K Cells Sales in Volume by Country (2024-2029)
6.2.2 Europe K Cells Sales in Value by Country (2024-2029)
7 Asia-Pacific K Cells by Region
7.1 Asia-Pacific K Cells Historic Market Size by Region
7.1.1 Asia-Pacific K Cells Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific K Cells Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific K Cells Sales in Value by Region (2018-2023)
7.2 Asia-Pacific K Cells Forecasted Market Size by Region
7.2.1 Asia-Pacific K Cells Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific K Cells Sales in Value by Region (2024-2029)
8 Latin America K Cells by Country
8.1 Latin America K Cells Historic Market Size by Country
8.1.1 Latin America K Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America K Cells Sales in Volume by Country (2018-2023)
8.1.3 Latin America K Cells Sales in Value by Country (2018-2023)
8.2 Latin America K Cells Forecasted Market Size by Country
8.2.1 Latin America K Cells Sales in Volume by Country (2024-2029)
8.2.2 Latin America K Cells Sales in Value by Country (2024-2029)
9 Middle East and Africa K Cells by Country
9.1 Middle East and Africa K Cells Historic Market Size by Country
9.1.1 Middle East and Africa K Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa K Cells Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa K Cells Sales in Value by Country (2018-2023)
9.2 Middle East and Africa K Cells Forecasted Market Size by Country
9.2.1 Middle East and Africa K Cells Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa K Cells Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chipscreen Biosciences
10.1.1 Chipscreen Biosciences Company Information
10.1.2 Chipscreen Biosciences Introduction and Business Overview
10.1.3 Chipscreen Biosciences K Cells Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Chipscreen Biosciences K Cells Products Offered
10.1.5 Chipscreen Biosciences Recent Development
10.2 Affimed NV
10.2.1 Affimed NV Company Information
10.2.2 Affimed NV Introduction and Business Overview
10.2.3 Affimed NV K Cells Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Affimed NV K Cells Products Offered
10.2.5 Affimed NV Recent Development
10.3 Altor BioScience
10.3.1 Altor BioScience Company Information
10.3.2 Altor BioScience Introduction and Business Overview
10.3.3 Altor BioScience K Cells Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Altor BioScience K Cells Products Offered
10.3.5 Altor BioScience Recent Development
10.4 Innate Pharma
10.4.1 Innate Pharma Company Information
10.4.2 Innate Pharma Introduction and Business Overview
10.4.3 Innate Pharma K Cells Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Innate Pharma K Cells Products Offered
10.4.5 Innate Pharma Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda K Cells Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda K Cells Products Offered
10.5.5 Takeda Recent Development
10.6 Sorrento Therapeutics
10.6.1 Sorrento Therapeutics Company Information
10.6.2 Sorrento Therapeutics Introduction and Business Overview
10.6.3 Sorrento Therapeutics K Cells Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sorrento Therapeutics K Cells Products Offered
10.6.5 Sorrento Therapeutics Recent Development
10.7 NantKwest
10.7.1 NantKwest Company Information
10.7.2 NantKwest Introduction and Business Overview
10.7.3 NantKwest K Cells Sales, Revenue and Gross Margin (2018-2023)
10.7.4 NantKwest K Cells Products Offered
10.7.5 NantKwest Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb K Cells Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol-Myers Squibb K Cells Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 NKT
10.9.1 NKT Company Information
10.9.2 NKT Introduction and Business Overview
10.9.3 NKT K Cells Sales, Revenue and Gross Margin (2018-2023)
10.9.4 NKT K Cells Products Offered
10.9.5 NKT Recent Development
10.10 Henry Ford Health Services
10.10.1 Henry Ford Health Services Company Information
10.10.2 Henry Ford Health Services Introduction and Business Overview
10.10.3 Henry Ford Health Services K Cells Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Henry Ford Health Services K Cells Products Offered
10.10.5 Henry Ford Health Services Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 K Cells Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 K Cells Industrial Chain Analysis
11.4 K Cells Market Dynamics
11.4.1 K Cells Industry Trends
11.4.2 K Cells Market Drivers
11.4.3 K Cells Market Challenges
11.4.4 K Cells Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 K Cells Distributors
12.3 K Cells Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
